Last 645.00
Change Today 0.00 / 0.00%
Volume 0.0
WDMD On Other Exchanges
Tel Aviv
As of 10:24 AM 12/25/14 All times are local (Market data is delayed by at least 15 minutes).

widemed (WDMD) Snapshot

Previous Close
Day High
Day Low
52 Week High
09/1/14 - $3,980
52 Week Low
12/18/14 - $645.00
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for WIDEMED (WDMD)

Related News

No related news articles were found.

widemed (WDMD) Related Businessweek News

No Related Businessweek News Found

widemed (WDMD) Details

WideMed Ltd. develops Web-based and automated sleep diagnostic software products for the sleep clinical market in Israel. Its signal processing technology is used for the analysis of non-stationary life-sign signals, such as EEG, respiratory, ECG, blood saturation, and others. The company offers Morpheus, which is an automated sleep testing management solution that is used in laboratories and hospitals with full PSG’s or with any ambulatory device for home sleep testing. Its products also include Morpheus Hx, which is Web-based computer software for use as an aid to the diagnosis of respiratory-related sleep disorders; and Morpheus Ox, a portable home sleep diagnostic and monitoring solution that measures plethysmography, blood saturation, heart rate, and activity signals. The company was founded in 2000 and is headquartered in Herzliya, Israel.

Founded in 2000

widemed (WDMD) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

widemed (WDMD) Key Developments

Dehaier Medical Systems Limited and WideMed Extends Exclusive Strategic Partnership for Six More Years

Dehaier Medical Systems Ltd. announced that it has signed a new software license and strategic cooperation agreement with WideMed Technologies Ltd. during the MEDICA trade fair, which took place November 16 -19, 2014 in Düsseldorf, Germany. Delegates from both the Chinese and Israeli governments witnessed the signing of the New Agreement this week at MEDICA. The New Agreement gives Dehaier six more years of exclusive right in China to offer WideMed's cost-effective, portable home sleep diagnostic and analysis software solution, Morpheus OX. Both parties also agreed to leverage WideMed's innovative cloud-based automatic sleep diagnostic and analysis software and Dehaier's cost-effective wearable hardware solution to fully cooperate on the development and marketing of turnkey solution systems for Obstructive Sleep Apnea Syndrome both in China and abroad. Dehaier will further research and develop the wearable sleep diagnostic device for sale in international markets and will actively pursue international certifications for the device.

WideMed Ltd., Special/Extraordinary Shareholders Meeting, Sep 10, 2014

WideMed Ltd., Special/Extraordinary Shareholders Meeting, Sep 10, 2014.

WideMed Ltd., Annual General Meeting, Jul 17, 2014

WideMed Ltd., Annual General Meeting, Jul 17, 2014., at 10:00 Israel Standard Time.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
WDMD:IT 645.00 0.00

WDMD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for WDMD.
View Industry Companies

Industry Analysis


Industry Average

Valuation WDMD Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact WIDEMED, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at